Assisted Living in the United States: an Open Dataset
Authors:
Anton Stengel,
Jaan Altosaar,
Rebecca Dittrich,
Noemie Elhadad
Abstract:
An assisted living facility (ALF) is a place where someone can live, have access to social supports such as transportation, and receive assistance with the activities of daily living such as toileting and dressing. Despite the important role of ALFs, they are not required to be certified with Medicare and there is no public national database of these facilities. We present the first public dataset…
▽ More
An assisted living facility (ALF) is a place where someone can live, have access to social supports such as transportation, and receive assistance with the activities of daily living such as toileting and dressing. Despite the important role of ALFs, they are not required to be certified with Medicare and there is no public national database of these facilities. We present the first public dataset of ALFs in the United States, covering all 50 states and DC with 44,638 facilities and over 1.2 million beds. This dataset can help provide answers to existing public health questions as well as help those in need find a facility. The dataset was validated by replicating the results of a nationwide study of ALFs that uses closed data [4], where the prevalence of ALFs is assessed with respect to county-level socioeconomic variables related to health disparity such as race, disability, and income. To showcase the value of this dataset, we also propose a novel metric to assess access to community-based care. We calculate the average distance an individual in need must travel in order to reach an ALF. The dataset and all relevant code are available at github.com/antonstengel/assisted-living-data.
△ Less
Submitted 4 February, 2023; v1 submitted 28 December, 2022;
originally announced December 2022.
Enhancing Early Lung Cancer Detection on Chest Radiographs with AI-assistance: A Multi-Reader Study
Authors:
Gaetan Dissez,
Nicole Tay,
Tom Dyer,
Matthew Tam,
Richard Dittrich,
David Doyne,
James Hoare,
Jackson J. Pat,
Stephanie Patterson,
Amanda Stockham,
Qaiser Malik,
Tom Naunton Morgan,
Paul Williams,
Liliana Garcia-Mondragon,
Jordan Smith,
George Pearse,
Simon Rasalingham
Abstract:
Objectives: The present study evaluated the impact of a commercially available explainable AI algorithm in augmenting the ability of clinicians to identify lung cancer on chest X-rays (CXR).
Design: This retrospective study evaluated the performance of 11 clinicians for detecting lung cancer from chest radiographs, with and without assistance from a commercially available AI algorithm (red dot,…
▽ More
Objectives: The present study evaluated the impact of a commercially available explainable AI algorithm in augmenting the ability of clinicians to identify lung cancer on chest X-rays (CXR).
Design: This retrospective study evaluated the performance of 11 clinicians for detecting lung cancer from chest radiographs, with and without assistance from a commercially available AI algorithm (red dot, Behold.ai) that predicts suspected lung cancer from CXRs. Clinician performance was evaluated against clinically confirmed diagnoses.
Setting: The study analysed anonymised patient data from an NHS hospital; the dataset consisted of 400 chest radiographs from adult patients (18 years and above) who had a CXR performed in 2020, with corresponding clinical text reports.
Participants: A panel of readers consisting of 11 clinicians (consultant radiologists, radiologist trainees and reporting radiographers) participated in this study.
Main outcome measures: Overall accuracy, sensitivity, specificity and precision for detecting lung cancer on CXRs by clinicians, with and without AI input. Agreement rates between clinicians and performance standard deviation were also evaluated, with and without AI input.
Results: The use of the AI algorithm by clinicians led to an improved overall performance for lung tumour detection, achieving an overall increase of 17.4% of lung cancers being identified on CXRs which would have otherwise been missed, an overall increase in detection of smaller tumours, a 24% and 13% increased detection of stage 1 and stage 2 lung cancers respectively, and standardisation of clinician performance.
Conclusions: This study showed great promise in the clinical utility of AI algorithms in improving early lung cancer diagnosis and promoting health equity through overall improvement in reader performances, without impacting downstream imaging resources.
△ Less
Submitted 31 August, 2022;
originally announced August 2022.
